tirzepatide logo Mounjaro® (tirzepatide) injection and Zepbound® (tirzepatide) injection Tirzepatide Weight Loss Brochure |

Description

Current clinical trials involving tirzepatide As of December 16, 2023, Clinicaltrials.gov lists 17 ongoing studies involving tirzepatide, with primary outcomes focusing on changes in body weight and HbA1c levels in patients with T2D, obesity, or overweight [2]

[1] [2] Currently, there is limited human data regarding tirzepatide use during pregnancy and its potential effects on fetal development

Details are in the bacteriostatic water guide

While the 122 patent expires on March 20, 2026, its related patent, 343, will expire over five years later on December 5, 2031

A Florida judge on Tuesday dismissed Eli Lillys case against a compounding pharmacy, finding that the drugmaker cannot use state law in its campaign against reformulated versions of the companys top-selling weight-loss and diabetes medication tirzepatide